Two days of discussion and study dedicated to new therapeutic frontiers for the treatment of highly active relapsing multiple sclerosis. The event organized by the global pharmaceutical company Merck, entitled 'Space of care: as one for patients', brought together academics and clinicians from Italian centers of excellence in Milan, who presented the new efficacy and safety data derived from the use of cladribine in clinical practice.
#Multiple #sclerosis #data #efficacy #safety #cladribine #presented #twoday #Merck #event
